Experimental vaccine guards against three respiratory viruses
Researchers have found that an experimental trivalent vaccine may provide protection against three of the most prominent respiratory viruses: seasonal influenza, COVID-19, and respiratory syncytial virus. The vaccine demonstrated an effective protective immune response in mice and ferrets, with the ability to stimulate antibody levels comparable to those produced by single-virus vaccines. The research focuses on developing a multivirus vaccine with a single dose, emphasizing the need for further studies to confirm its effectiveness.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)